John L. Leguyader

Array ( [id] => 3509098 [patent_doc_number] => 05563050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Antisense oligonucleotides against HSV 1, and their preparation' [patent_app_type] => 1 [patent_app_number] => 8/281082 [patent_app_country] => US [patent_app_date] => 1994-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9515 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563050.pdf [firstpage_image] =>[orig_patent_app_number] => 281082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3680925 [patent_doc_number] => 05633133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Ligation with hammerhead ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/275156 [patent_app_country] => US [patent_app_date] => 1994-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 3585 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633133.pdf [firstpage_image] =>[orig_patent_app_number] => 275156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3729696 [patent_doc_number] => 05693535 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'HIV targeted ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/271880 [patent_app_country] => US [patent_app_date] => 1994-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 30 [patent_no_of_words] => 22770 [patent_no_of_claims] => 100 [patent_no_of_ind_claims] => 98 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693535.pdf [firstpage_image] =>[orig_patent_app_number] => 271880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3694820 [patent_doc_number] => 05595873 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'T. thermophila group I introns that cleave amide bonds' [patent_app_type] => 1 [patent_app_number] => 8/270180 [patent_app_country] => US [patent_app_date] => 1994-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 35636 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595873.pdf [firstpage_image] =>[orig_patent_app_number] => 270180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4328356 [patent_doc_number] => 06312953 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Bifunctional Crosslinking oligonucleotides adapted for linking to a target sequence of duplex DNA' [patent_app_type] => 1 [patent_app_number] => 8/266949 [patent_app_country] => US [patent_app_date] => 1994-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9820 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/312/06312953.pdf [firstpage_image] =>[orig_patent_app_number] => 266949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3523169 [patent_doc_number] => 05527674 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-18 [patent_title] => 'Genetic construct for selection of homologous recombinants on a single selective medium' [patent_app_type] => 1 [patent_app_number] => 8/236957 [patent_app_country] => US [patent_app_date] => 1994-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8523 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 205 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/527/05527674.pdf [firstpage_image] =>[orig_patent_app_number] => 236957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3696404 [patent_doc_number] => 05595978 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-21 [patent_title] => 'Composition and method for treatment of CMV retinites' [patent_app_type] => 1 [patent_app_number] => 8/233711 [patent_app_country] => US [patent_app_date] => 1994-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7116 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/595/05595978.pdf [firstpage_image] =>[orig_patent_app_number] => 233711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3647306 [patent_doc_number] => 05639655 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'PML-RARA targeted ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/233030 [patent_app_country] => US [patent_app_date] => 1994-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13385 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639655.pdf [firstpage_image] =>[orig_patent_app_number] => 233030 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725931 [patent_doc_number] => 05681934 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => '47-kilodalton antigen of Treponema pallidum' [patent_app_type] => 1 [patent_app_number] => 8/226486 [patent_app_country] => US [patent_app_date] => 1994-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 16245 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681934.pdf [firstpage_image] =>[orig_patent_app_number] => 226486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3915515 [patent_doc_number] => 06001989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'Nucleotide based endonucleases' [patent_app_type] => 1 [patent_app_number] => 8/218656 [patent_app_country] => US [patent_app_date] => 1994-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 10148 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001989.pdf [firstpage_image] =>[orig_patent_app_number] => 218656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934176 [patent_doc_number] => 05972701 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-26 [patent_title] => 'Nucleotide based endonucleases' [patent_app_type] => 1 [patent_app_number] => 8/218613 [patent_app_country] => US [patent_app_date] => 1994-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 1 [patent_no_of_words] => 10195 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/972/05972701.pdf [firstpage_image] =>[orig_patent_app_number] => 218613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3748010 [patent_doc_number] => 05717058 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-10 [patent_title] => 'Peptide inhibitors of tax-dependent transcription' [patent_app_type] => 1 [patent_app_number] => 8/199508 [patent_app_country] => US [patent_app_date] => 1994-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34006 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/717/05717058.pdf [firstpage_image] =>[orig_patent_app_number] => 199508 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3610640 [patent_doc_number] => 05589580 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-31 [patent_title] => 'Ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/195747 [patent_app_country] => US [patent_app_date] => 1994-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 38 [patent_no_of_words] => 11423 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/589/05589580.pdf [firstpage_image] =>[orig_patent_app_number] => 195747 [rel_patent_id] =>[rel_patent_doc_number] =>)